Skip to main content

Table 3 Susceptibility of gram-positive organisms isolated from cerebrospinal fluid and brain abscess specimen sources. TSN Database USA 2000–2002.

From: Prevalence of antimicrobial resistance in bacteria isolated from central nervous system specimens as reported by U.S. hospital laboratories from 2000 to 2002

  

Cerebrospinal fluid

Brain abscess

Organism

Antimicrobial

Total n

%Sa

%R

Total n

%S

%R

Enterococcus faecalis

ampicillin

229

98.7

1.3

NDb

ND

ND

 

chloramphenicol

79

79.7

15.2

ND

ND

ND

 

levofloxacin

136

81.6

18.4

ND

ND

ND

 

penicillin

165

99.4

0.6

ND

ND

ND

 

rifampin

58

58.6

17.2

ND

ND

ND

 

vancomycin

239

98.7

1.3

ND

ND

ND

Enterococcus faecium

ampicillin

93

15.1

84.9

ND

ND

ND

 

chloramphenicol

54

92.6

0

ND

ND

ND

 

levofloxacin

56

12.5

85.7

ND

ND

ND

 

penicillin

50

22.0

78.0

ND

ND

ND

 

rifampin

30

56.7

30.0

ND

ND

ND

 

vancomycin

96

38.5

61.5

ND

ND

ND

Viridans group Streptococci

ampicillin

95

62.1

6.3

10

90.0

0

 

cefotaxime

174

85.1

9.8

32

96.9

3.1

 

ceftriaxone

220

87.3

9.1

33

93.9

3.0

 

chloramphenicol

100

96.0

3.0

14

92.9

0

 

meropenem

19

100

0

13

100

0

 

levofloxacin

90

96.7

1.1

24

100

0

 

penicillin

437

63.2

5.3

72

97.2

1.4

 

vancomycin

396

100

-e

44

100

0

Streptococcus pneumoniae

cefotaxime

313

80.5

7.7 (19.5 NSc)

ND

ND

ND

 

ceftriaxone

404

85.4

3.5 (14.6 NS)

ND

ND

ND

 

chloramphenicol

180

96.1

3.9 (3.9 NS)

ND

ND

ND

 

meropenem

76

78.9

7.9 (21.1 NS)

ND

ND

ND

 

levofloxacin

283

100

0

ND

ND

ND

 

penicillin

565

59.5

16.6 (40.5 NS)

ND

ND

ND

 

rifampin

70

100

0

ND

ND

ND

 

TMP-SMXd

233

65.2

27.5 (34.8 NS)

ND

ND

ND

 

vancomycin

453

100

-

ND

ND

ND

  1. aNCCLS interpretation for susceptible (S) and resistant (R) according to NCCLS guidelines [8]bND – No data cNS – Percent non-susceptible (including intermediate and resistant isolates) dTMP-SMX – Trimethoprim-sulfamethoxazole eDashed line indicates that NCCLS breakpoints do not currently exist to interpret results as resistant